Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Akeso announced the China National Medical Products Administration has accepted the supplemental new drug application of cadonilimab PDCTLA bispecific antibody
JW Therapeutics an independent and innovative biotechnology company focusing on developing manufacturing and commercializing cell immunotherapy products announced that the National Medical Products Administration
ITM Isotope Technologies Munich SE a leading radiopharmaceutical biotech company today announced the receipt of the Radioactive Material Handling License for the companys NOVA facility
Turn Biotechnologies a developer of novel mRNA medicines and enabling technologies today announced the expansion of its eTurna delivery platform that is expected to overcome the greatest challenge
Belief BioMed Group an industryleading biotech company focusing on innovative gene therapies announced the completion of first subject dosing in its registrational clinical trial
GPN Vaccines Ltd a clinicalstage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent lifethreatening pneumonia bacteraemia and meningitis is pleased to announce
Allorion Therapeutics a US and Chinabased biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases has entered into an exclusive option
Sciwind Biosciences Co Ltd a clinicalstage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic diseases today announced positive
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology metabolic autoimmune
Galapagos NV and Alfasigma SpA today announced that they have signed an agreement to transfer Galapagos Jyseleca business to Alfasigma marking a significant milestone in Galapagos transformation into an innovative biotechnology
